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Summary 
Bacterial endospores (spores) have a higher intrinsic resistance to 
microbicides as compared to other microbial forms, most likely due to their 
impermeable outer layers and low water content. Though structural 
differences between the spores of various bacterial species may account for 
observed variations in their resistance to microbicides, flaws in methods for 
testing the sporicidal activity of microbicides often exaggerate the differences. 
This has major implications when considering the selection of one or more 
surrogates to assess microbicides against clinically relevant spore-formers 
such as Clostridium difficile. The mounting significance of C. difficile as a 
pathogen is leading to a corresponding increase in the number of 
commercially available microbicidal formulations claiming activity against its 
spores without proper differentiation between the product’s sporistatic and 
sporicidal actions. In this review we critically assess the situation and the 
implications of product claims on the field use of microbicidal products.  
 
Introduction 
When applied to surface disinfection treatments, the terms “microbicidal” and 
“microbistatic” relate to a chemical’s ability to either kill or actively prevent the 
growth of a given microorganism, respectively.  In reality however, the 
distinction between the two definitions is not so straightforward; many 
microbistatic treatments may exhibit a microbicidal activity depending on 
concentration, temperature and/or contact time. Conversely, microbicidal 
formulations may demonstrate “static” activity at lower concentrations or 
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under sub-optimal conditions of exposure time or temperature (Maillard, 2002; 
Pankey and Sabath, 2004; Maillard and McDonnell, 2012).  The distinction 
between these two terms is further blurred when applied to bacterial spores, 
which are naturally under self-imposed ‘stasis’ or ‘dormancy’ without any 
exposure to microbicides.  The transformation of a spore to an actively 
dividing vegetative form is a multi-stage process including germination, 
outgrowth and binary fission (Leggett et al., 2012). 
Simply put, any sporicidal treatment must achieve a complete and permanent 
loss of the spore’s ability to germinate and grow. In contrast, exposure to a 
sporistatic treatment may temporarily arrest its ability to germinate without 
affecting its viability. Owing to the relatively complex cascade of events taking 
place during the transformation of a spore to a vegetative cell (outlined 
below), both these definitions are open to misrepresentation/interpretation as 
they give no clear indication as to how, or at which stage of the transformation 
process a treatment inhibits the progression from spore to vegetative cell, or 
whether it is vegetative cell growth itself which is inhibited (Russell, 1982). 
The life-cycle of a spore-forming bacterium can be described as a continuum 
from vegetative cell growth to dormant spore and back again via the 
processes of sporulation, germination and outgrowth.  Germination can be 
further broken down into several defined stages (Setlow, 2003) of which 
stage-I encompasses those events taking place prior to the degradation of the 
spore cortex, including the release into the surrounding medium of many of 
the spore core’s constituents (various cations and the spore’s large depot of 
dipicolinic acid (DPA) which is chelated with divalent cations, predominantly 
Ca2+), and is accompanied by some core hydration, while stage-II sees the 
 4 
degradation of the spore’s peptidoglycan cortex and further hydration and 
expansion of the core. This precedes the onset of outgrowth where 
metabolism and macromolecular synthesis are re-initiated, along with the 
degradation of the spores’ DNA-protective small acid-soluble spore proteins 
(SASPs) and shedding of the spore coat, returning the bacterium to 
vegetative cell growth (Russell, 1982; Setlow, 2003; Leggett et al., 2012).   
As discussed below, much of the confusion surrounding characterisation of a 
treatment as either sporicidal or sporistatic centres on the question, “when is a 
spore no longer a spore?” This review presents the finer details of sporicidal 
or sporistatic treatments in order to clarify certain aspects of these definitions 
in light of the more recent literature and discuss practical implications on 
testing of sporicidal formulations and on disinfection regimes.  
 
Sporicidal and sporistatic activity of microbicidal treatments 
The usual microbicides with documented sporicidal activity are briefly listed in 
Table 1. It is not intended that this review should provide an exhaustive list of 
chemical classes and their activity against bacterial spores (readers wishing 
for such information are referred to McDonnell and Russell (1999) and 
Maillard (2011), but rather to discuss clarification of the terminology and its 
implications.  
 
Sporistatic activity – inhibition of spore germination process 
Sporistatic treatments should be defined as those that specifically prevent 
spore germination only (Fig. 1b).  The spore remains dormant and viable and 
can, therefore, resume the germination process upon removal/neutralisation 
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of the inhibiting agent (see “exception that proves the rule” below). In other 
words, ‘sporistasis’ is a transient and reversible state. 
References to sporistatic activity in the literature are often somewhat 
confusing as they encompass treatments that prevent both spore germination 
(which does not require an assessment of microbial growth or colony 
formation) and/or outgrowth (most commonly assessed by colony 
formation/growth).  The main element of confusion here is that outgrowth is 
not an intrinsic property of the dormant spore, and therefore should not 
necessarily be associated with the prefix “spori” at all, but should be referred 
instead as bactericidal or bacteristatic.  Below are given some examples of 
various microbicidal treatments and an explanation of their classification 
according to our definition. 
Several cationic microbicides, e.g. the quaternary ammonium compounds 
benzalkonium chloride and cetylpyridinium chloride, or the bisbiguanide 
chlorhexidine, do not inhibit spore germination although they do prevent 
progression through outgrowth if not effectively neutralised and are commonly 
described as sporistatic in the literature (Fig 1b; legend scenario iv) (Russell 
et al., 1985; Shaker et al., 1986; Russell, 1998). We suggest that such 
treatments not be classed as sporistatic as they do not inhibit any intrinsic 
property of the dormant spore.  Indeed, it is commonly remarked in the 
literature that “sporistatic” concentrations of such microbicides are very similar 
to those that inhibit vegetative cells (Russell, 1990, 1998).  Therefore, it would 
seem likely that such activity against spore outgrowth is bacteristatic or 
bactericidal but not sporistatic as often mentioned. It should be noted that 
under certain conditions, such as alkalinisation, acidification and increased 
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ionic strength, treatment with at least chlorhexidine can become sporicidal 
(Nerandzic et al., 2015; Nerandzic and Donskey 2015). 
Whilst in the presence of some microbicides, bacterial spores are prevented 
from germinating but undergo no readily measurable damage, and remain in a 
dormant state. The spores are eventually able to return to vegetative growth 
following removal/neutralisation of the microbicide (Fig. 1b; legend scenario 
v).  Such a treatment has not compromised the viability of the spore and 
should therefore be considered sporistatic.  Phenol and cresol are two 
examples of sporistatic treatments. Spores exposed to them undergo no 
detectable germination in broth (as measured by a decrease in optical 
density; OD), although they proceed through outgrowth if these chemicals are 
removed, by membrane filtration, for example (Parker, 1969; Russell et al., 
1985). 
 
Sporicidal activity   
Sporicidal treatments are those that result in the irreversible loss of spore 
viability, although the situation is more complicated than for bactericidal 
activity. 
Some treatments (e.g., strong acids) cause spores to rupture, rendering them 
unable to germinate or form a colony on a plate regardless of any subsequent 
treatments e.g. neutralisation of the acid or treatment with lysozyme (Fig. 1a; 
legend scenario i) (Setlow et al., 2002).  Such a treatment is certainly 
sporicidal as spore viability is unquestionably compromised. 
Oxidising agents are commonly used as sporicides (Maillard, 2011) and, 
given specific treatment conditions, can result in spore lysis as described 
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above for strong acids (King and Gould, 1969).  However, treatment with 
oxidising agents such as hydrogen peroxide, sodium hypochlorite and 
peracetic acid does not necessarily result in spore lysis.  Following exposure 
to these oxidising agents, spores are left unable to form colonies even after 
neutralisation of the microbicide. A subsequent lysozyme treatment of such 
treated spores can often give apparent spore germination, but these 
germinated spores exhibit little or no metabolic activity and do not outgrow 
(Melly et al., 2002; Young and Setlow, 2003; Setlow et al., 2013).  Likewise 
Russell (1982) observed that the recovery of microbicide-treated spores was 
influenced markedly by some additions to recovery media, and also the 
recovery temperature(s). How then should such treatments be classified?  
Firstly, given that every effort was made to neutralise/remove the microbicide 
completely, the observed activity can neither be sporistatic as outlined above, 
nor can it be bacteristatic/cidal (i.e. from residual activity from any remaining 
microbicide) (Fig. 1b; legend scenario iv & v).  Secondly, as the treated 
spores cannot be revived by treatment with lysozyme, the activity is not 
sporistatic as described below (Fig. 1b; legend scenario vi).  Finally, spores 
are not lysed by the treatment, and yet are clearly inactivated. A compromised 
inner membrane may be the reason for spore inactivation (Shapiro and 
Setlow, 2005).  Such a treatment should therefore be considered sporicidal 
(Fig. 1a; legend scenario iii).   
 
2.3 The exception that proves the rule 
There is at least one example of a sporistatic treatment that does not fit our 
definitions, and yet is not truly sporicidal (Fig. 1b; legend scenario vi).  Spores 
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treated with sodium hydroxide (NaOH), followed by complete 
removal/neutralisation do not form colonies on a medium that ordinarily 
supports their growth (Setlow et al., 2002); such a treatment would appear 
sporicidal at first glance.  However, spores may be completely recovered if 
plated on a medium containing lysozyme, indicating no loss in spore viability; 
this treatment is therefore not sporicidal.  This is most likely a result of 
damage sustained to part of the spore’s germination apparatus, the cortex 
lytic enzymes (CLE) which are required for degradation of the spore’s thick 
peptidoglycan cortex during germination allowing the spore to swell and return 
to the vegetative state (Ishikawa et al., 1998; Setlow et al., 2001; Setlow et al., 
2002).  In the absence of any functional CLE, the spore is trapped at Stage I 
of germination and cannot return to the vegetative state, but remains viable 
and may be recovered by lysozyme treatment (Popham et al., 1996; Setlow et 
al., 2001; Paredes-Sabja et al., 2009; Burns et al., 2010). In this instance, 
NaOH should be considered sporistatic, with the caveat that it does not 
conform strictly to our definition owing to the fact that such spores are able to 
partially germinate. Of course, this raises the question of what constitute 
reasonable recovery conditions. 
 
Suitable methods of assessing sporicidal and sporistatic activities 
 
Sporistatic activity 
Historically, a microbicidal treatment would be assigned as sporistatic based 
on minimum inhibitory concentration (MIC) values determined using broth or 
agar dilution methods, where the lowest concentration of the microbicide 
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preventing growth in broth is designated the MIC, or minimum sporistatic 
concentration for spores (Russell, 1998).  However, in reality, such a method 
is unsuitable for definitively assessing spore susceptibility, as no information 
can be gained as to which stage, germination, outgrowth/vegetative cell 
growth or all of these, is/are being inhibited. Consequently, the observed 
activity could be sporicidal, sporistatic i.e. inhibiting germination, or 
bactericidal/static by inhibiting outgrowth/vegetative growth. 
According to our definition, sporistatic treatments are those that specifically 
inhibit germination, and not outgrowth/vegetative growth. Therefore, any 
assessment of sporistatic activity cannot rely on microbial growth, and must 
be able to distinguish germination from outgrowth/vegetative growth.  Several 
methods may be used to track spore germination, including direct observation 
of spore refractivity under a phase-contrast microscope (spore refractivity 
decreases during germination and can be observed as a transition from phase 
bright to phase dark spores), monitoring the optical density of a spore 
population (as the OD of a spore population decreases ~ 60% during 
germination) or by assaying for pyridine-2,6-dicarboxylic acid (dipicolinic acid 
– DPA) released during spore germination using a fluorometric analysis 
(Russell, 1998; Hindle and Hall, 1999; Yi and Setlow, 2010). Spore 
germination requirements, and especially outgrowth can change after putative 
microbicide treatment, as treated spores often required very rich media, and 
are more sensitive to salt in plating media. Other, more intricate analyses can 
also monitor the germination of individual spores such as phase-contrast 
microscopy (or differential interference contrast microscopy) in combination 
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with Raman spectroscopy to monitor DPA release (Kong et al., 2010; Zhang 
et al., 2010). 
Following assessment of germination, spores must also be assessed for 
viability, as only those treatments, which temporarily prevent spore 
germination should be characterised as sporistatic, and upon removal of the 
inhibition (or following reasonable recovery conditions – see below) the 
spores should germinate normally, returning to vegetative growth.  If spores 
do not return to vegetative growth then the process should be further 
investigated for sporicidal activity as outlined below.  Note that a return to 
vegetative growth is dependent upon complete neutralisation of any 
microbicide, and the presence of a growth -medium, and as such, would have 
to be assessed separately from the assessment of germination.  Additionally, 
successful germination alone cannot be taken as a definitive indication of 
spore viability, as some treatments result in spores that germinate relatively 
normally, but do not outgrow and do not give rise to growing cells (Setlow et 
al., 2013). 
 
Sporicidal activity 
Sporicidal activity of microbicides is conventionally assessed using a 
suspension test, such as the BS EN 13704 standard efficacy test where 
spores are exposed to a chemical for a given contact time after which the 
chemical is removed by membrane filtration and/or neutralised using an 
appropriate neutraliser and the colony formation resulting from the 
germination and outgrowth of viable spores enumerated on a growth medium 
(Humphrey, 2011; Table 2).  In North America only carrier tests are used for 
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that purpose. They are based on the standards of either AOAC International 
or ASTM International (Humphrey, 2011; Table 2). Whatever the standard 
sporicidal test, appropriate neutralisation is essential in order to correctly 
characterise a sporicidal process, as any remaining microbicide could have a 
sporistatic activity on the surviving spore population (Fig. 1b; legend scenario 
v) or a bacteriostatic/cidal activity on the germinated or outgrowing spore (Fig. 
1b; legend scenario iv), both of which would be mischaracterised as sporicidal 
under this test procedure. 
 
Conclusions 
This review aimed to refine the definition of sporistatic and sporicidal activity. 
One important question is whether preventing spore germination (sporistatic) 
or inactivating the spores (sporicidal) really matters in practice or not. 
Sporistasis remains a transient condition whereby if the selective pressure is 
removed the spore remains viable with the potential for outgrowth. In this 
review we mentioned the ability of lytic enzymes such as lysozymes to 
resurrect inactivated spores. When this principle is applied to Clostridium 
difficile, one can wonder if a viable spore that cannot germinate following a 
microbicidal treatment, could do so in the human gut, which is rich in 
lysozymes. Most protocols designed to cultivate C. difficile from the 
environment now utilise lysozyme in the growth media to promote recovery, 
but the use of lysozymes is not widespread in sporicidal standard efficacy 
tests. 
Many products claiming sporicidal activity are based on one or more 
quaternary ammonium compounds (QAC) (Siani et al., 2011), which often 
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makes their effective neutralisation difficult (Zhang et al., 2010). This can 
result in a sporistatic or/and bacteristatic/cidal activity as mentioned in this 
review. But whether this is due to action on the germinated spores or the 
process of outgrowth is most often not clear. Thus an inhibitor of DNA 
replication would act only late in outgrowth, while a protein synthesis inhibitor 
would act to block outgrowth. Further research is clearly needed to ascertain 
how proper neutralisation or removal of the active agent(s) can be achieved to 
ensure that claims for sporicidal activity are based on solid experimental data. 
At the same time, the practical application of sporistasis, notably with 
pathogens such as C. difficile, needs to be better understood and the pitfalls 
in use of any sporistatic agent need to be appreciated. 
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Table 1. Examples of sporicidal chemicals 
Chemical class Chemical Comments 
Alkylating 
agents 
Ethylene oxide (8.5-
100%) 
- Gas which can be used alone or in 
combination with other carrier gases 
- Articles need aeration following exposure 
 Glutaraldehyde (2-
3.5%) 
- Sporicidal activity requires 3 hours or more 
at room temperature 
- Raising of pH (activation) often required for 
a general enhancement in microbicidal 
activity 
 
ortho-
phthalaldehyde 
(0.55%)  
- Requires 24-30 hours at room temperature 
for sporicidal activity  
 Formaldehyde 
(37%) 
- Can be used as gas (from 
paraformaldehyde) or liquid 
- Can be used in combination with ethanol 
- Articles need aeration following exposure 
Oxidising 
agents 
Hydrogen peroxide 
(0.5-70%) 
- Can be used as liquid, vapour or gas 
plasma 
- Sporicidal activity in liquid form requires 
acidic pH and addition of stabilizers and 
accelerants  
- May be used in combination with other 
oxidisers such as peracetic acid 
 Peracetic or 
peroxyacetic acid 
(0.05-1%) 
- A strong and fast-acting sporicidal 
chemical 
- Can be generated inside certain types of 
automated endoscope reprocessors 
 Chlorine dioxide 
(150 ppm) 
- Requires on-site generation by mixing citric 
acid with a solution of sodium chlorite  
 Ozone - A powerful oxidising gas 
- Its activity is severely affected by organic 
matter, low temperature and relative 
 18 
humidity. 
Chlorine-
releasing 
agents 
Sodium hypochlorite 
(5.5-12%) 
- Commonly referred to as chlorine bleach 
- Acidification can accelerate sporicidal 
action 
Sodium 
dichloroisocyanurate 
-  Less susceptible to inactivation by organic 
matter 
- Less corrosive than hypochlorites 
 Chloramine-T -  More stable that hypochlorite 
-   Efficacy probably linked to the release of 
HOCl following hydrolyses explaining a 
slow microbicidal action compared to 
hypochlorites 
 Calcium 
hypochlorite 
- Calcium hypochlorite products are soluble 
in water and stable over long storage time. 
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Table 2 Common standard tests use to determine the sporicidal activity of a 
product 
 
Test 
designation 
Type of test Organism(s) used 
European Committee for Standardization (http://www.cen.eu/Pages/default.aspx; accessed 
September 2015)  
EN14347 Basic sporicidal activity - (phase 1) – 
suspension test 
B. subtilis 
EN13704 Quantitative suspension test (phase 2, step 1) B. subtilis 
ASTM International (http://www.astm.org/; accessed September 2015)   
E2111 Glass vials – surface test B. subtilis and Clostridium 
sporogenes 
E2197 Stainless steel disks – surface test B. subtilis and C. sporogenes 
AOAC International (http://www.aoac.org/iMIS15_Prod/AOAC; accessed September 2015)   
AOAC 
International 
(996.04) 
Porcelain cylinders and silk or Dacron suture 
loops – surface test 
B. subtilis and C. sporogenes 
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Figure 1.  An illustration of the potential outcomes from a microbicide 
treatment of bacterial spores.  Altogether seven scenarios can be 
presented. 
a) Scenarios leading to a sporicidal activity 
Scenario i) The spore is treated with a microbicide/formulation (1), which is 
neutralised completely (2), and results in lysis of the spore (3).  The 
microbicide/formulation is therefore sporicidal.   
Scenario ii) The spore is treated with a microbicide/formulation (1), which is 
neutralised completely (2), but does not undergo or complete germination 
even with additional treatments (4).  Consequently the spore is unable to 
complete outgrowth and grow (5). The spore is inactivated. 
Scenario iii) The spore is treated with a microbicide/formulation (1), which is 
neutralised completely (2), and then undergoes germination (6).  However, 
the spore is unable to complete outgrowth (7) and thus is inactivated.  Such 
a microbicide/formulation is sporicidal. 
 
b) Scenarios leading to a sporicidal activity 
Scenario iv) The spore is treated with a microbicide/formulation (8) which is 
neutralised ineffectively (9) leaving residual microbicide in contact with the 
spore.  The spore germinates normally (10) thus losing much of their 
enhanced resistance properties leaving them vulnerable to the residual 
microbicide resulting in killing of the organism which therefore cannot 
complete outgrowth or start dividing (11).   
Scenario v) The spore is treated with a microbicide/formulation (8) which is 
not neutralised (9).  In the presence of this microbicide the spore is unable 
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to germinate (12).  This treatment is therefore sporistatic and upon 
complete removal of the microbicide (13) spores are able to complete 
germination and outgrowth, returning to vegetative cell growth.  
Scenario vi) The spore is treated with a microbicide/formulation (8), which is 
neutralised completely (14), but the spore still fails to germinate (15).  
However, the treated spores can be revived by additional treatment (e.g. 
exposure to lysozyme), which allows the spore to complete germination 
(16) and outgrowth returning to vegetative growth. The 
microbicide/formulation is therefore sporistatic, although the spore, which 
remains viable, but unable to germinate completely under normal 
conditions, could fall under the viable but non-cultivable (VNC) definition.   
Scenario vii) The spore is treated with a microbicide/formulation (8), which is 
neutralised completely (14), and then undergoes germination (17) and 
outgrowth (18) as normal and resumes vegetative cell growth.  Such a 
microbicide/formulation is neither sporicidal but may be sporistatic if the 
microbicide is not removed (scenario v).   
 
 
 
